Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
36511 participants
OBSERVATIONAL
2017-10-01
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Secondly, the heart failure risk score will be internally and externally validated, and compared with established heart failure risk scores. Additionally, the prevalence of heart failure as well as the distribution of the heart failure risk score in the general population will be evaluated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Heart Failure in Norway: Clinical Characteristics, Mortality and Health Care Resource Use
NCT04398563
Congestive Heart Failure Home Telemonitoring
NCT02048748
Remote Monitoring After Heart Failure
NCT05447598
Clinical Study of Active Intervention in High-risk HFpEF Patients
NCT06532019
Strategies for Assessment of Fluid Overload in Acute Decompensated Heart Failure
NCT04901039
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Validate the newly developed heart failure risk score internally in the HUNT2 database
Compare the predictive ability of the new heart failure risk score with established heart failure risk scores (the ABC Health HF risk score, the Framingham HF risk score) and an established Norwegian cardiovascular risk score (NORRISK 2)
Estimate the prevalence of likely ("undiagnosed") heart failure , i.e., patients at high risk of HF, in a general population by using both the established heart failure risk scores and the newly developed heart failure risk score, and compare the heart failure event rate between those at high risk of heart failure and those with established heart failure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants in the third wave of the HUNT study
General population participating in the third wave of the HUNT study
Heart failure risk estimation
Evaluation by heart failure risk score
Participants in the second wave of the HUNT study
General population participating in the second wave of the HUNT study
Heart failure risk estimation
Evaluation by heart failure risk score
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Heart failure risk estimation
Evaluation by heart failure risk score
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Missing vital data
18 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boehringer Ingelheim
INDUSTRY
Norwegian University of Science and Technology
OTHER
Vestre Viken Hospital Trust
OTHER
Helse Nord-Trøndelag HF
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Håvard Dalen, MSc, PhD
Role: STUDY_CHAIR
Helse Nord-Trøndelag HF
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Levanger hospital
Levanger, Norge, Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ofstad AP, Brunborg C, Johansen OE, Morkedal B, Fagerland MW, Laugsand LE, Gullestad LL, Dalen H. Development of a tool to predict the risk of incident heart failure in a general population: the HUNT for HF risk score. ESC Heart Fail. 2023 Oct;10(5):2807-2815. doi: 10.1002/ehf2.14390. Epub 2023 May 29.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LH-20H4HF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.